Rab, Croatia

Lorena Kordić

This inventor holds 2 USPTO granted patents. Top assignee: Assia Chemical Industries Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lorena Kordić. Retrieved from https://idiyas.com/inventor/lorena-kordić

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lorena Kordić: Innovator in Pharmaceutical Chemistry

Introduction

Lorena Kordić is a notable inventor based in Rab, Croatia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid-state forms of Mavacamten. Her work is essential for advancing therapeutic options in the medical field.

Latest Patents

Lorena holds a patent for "Solid state forms of Mavacamten and process for preparation thereof." This patent encompasses solid-state forms of Mavacamten, including crystalline polymorphs, processes for their preparation, and pharmaceutical compositions. This innovation is crucial for enhancing the efficacy and stability of Mavacamten in medical applications.

Career Highlights

Lorena Kordić is associated with Assia Chemical Industries Ltd., where she applies her expertise in pharmaceutical development. Her work at the company has been instrumental in advancing research and development in the field of chemical industries.

Collaborations

Lorena collaborates with her coworker, Dijana Škalec Šamec, who also contributes to the innovative projects at Assia Chemical Industries Ltd. Their partnership exemplifies the collaborative spirit in scientific research and development.

Conclusion

Lorena Kordić's contributions to pharmaceutical chemistry, particularly through her patent on Mavacamten, highlight her role as an innovator in the industry. Her work continues to impact the field positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…